Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
about
Hemolytic uremic syndromeManagement of hemolytic-uremic syndrome in children36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature.Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.Consequences of hemolytic uremic syndrome among hemodialysis patients.Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literatureCutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK.Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.Occurrence of atypical HUS associated with influenza B.Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship.Differing tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulationMolecular typing of Escherichia coli O157:H7 isolates from Swedish cattle and human cases: population dynamics and virulence.A Case of Microangiopathic Hemolytic Anemia after Myxoma Excision and Mitral Valve Repair Presenting as Hemolytic Uremic SyndromeNeurological Manifestations of Renal Diseases in Children in Qazvin/ IranFecal diagnostics in combination with serology: best test to establish STEC-HUS.New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.A devastating case of diarrhea-associated hemolytic uremic syndrome associated with extensive cerebral infarction; why we need to do better.Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications.Escherichia coli O121:H19 infection identified on microagglutination assay and PCR.
P2860
Q26799054-AA770D24-18A2-4EF3-84ED-221E96D2FC1DQ27002576-1DCF382B-5ED4-4512-A9BC-60B7596B1CF7Q33418663-8374BE43-032A-4066-AC0D-D76A26FAF7E0Q33419153-B81274EE-70DA-4CE0-9A0E-FC62F8B681A9Q33419244-023B00A4-D540-42A2-B4A8-EE86EDC1A55CQ33419812-932CFAB5-0048-461E-B71B-D61FF40473AFQ33421382-E47E911D-BB72-4EA7-8B92-A85C317D1BA9Q33423267-8072064C-8645-4E03-A5D9-6E575981D0EBQ33430817-FAE06D7E-3F1B-4AC8-A9D1-C102B6A04C1FQ33438621-7788610D-9363-435D-A8E0-AFC175953D14Q33439166-0BABC4B2-94A8-438A-8D71-40E1189F8EB7Q33441880-E311C137-1A0F-49E7-B077-6BEE43192377Q33908301-7D09F1FA-C797-4BD6-A281-CAAFF47E5379Q35035977-DF8CE75D-3434-48A6-9A9E-86C27B52F7EFQ36789070-7F040385-F58A-48E8-A5FD-4229723AC4C0Q37055543-8EFB9AAB-3DD3-4974-9E19-D6CEDCF072F3Q37290075-2DF7445A-1A38-4FCE-9357-B655CF325FFAQ38304445-BE77D6E4-4583-4B57-A130-D2D6603D2DB6Q38733660-A326346E-C0A6-40CE-922D-DFBFD87B0F94Q38900551-0B450A22-4E15-4D55-82C3-0454E6C7DD49Q54258059-17378BB3-950F-497E-B1B2-14C924211926
P2860
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@en
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@nl
type
label
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@en
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@nl
prefLabel
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@en
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@nl
P2860
P356
P1476
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
@en
P2093
Elisabetta Bertoni
Maurizio Salvadori
P2860
P356
10.5527/WJN.V2.I3.56
P577
2013-08-01T00:00:00Z